WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT:CVRS), a leading developer of precision vascular robotics, today announced that it will provide hands-on demonstrations of complex robotic-assisted percutaneous coronary intervention (PCI) using the CorPath® System at the 2016 Cardiovascular Research Technologies (CRT) meeting to be held in Washington, DC on February 20-23. CRT is a comprehensive interventional cardiology conference that attracts more than 2,000 interventional and cardiovascular specialists.

The CorPath System will be featured in several sessions:

"Robotic PCI: Practical Considerations for Adoption of Robotics in Your Cath Lab," a presentation by Dr. Robert Madder of Spectrum Health taking place on Tuesday, February 23 at 8:50 a.m.
"Robotically-assisted Peripheral Vascular Intervention,"* a presentation by Dr. Ehtisham Mahmud, Division Chief of Cardiovascular Medicine, Director of the Sulpizio Cardiovascular Center and Interventional Cardiology at UC San Diego taking place on Tuesday, February 23 at 9:00 a.m.
Participation in the Masters Transradial Intervention Course, a first-of-its-kind course dedicated to bringing together industry leaders to discuss the advancements of radial access adoption in the U.S. Corindus is a sponsor of the event along with a small group of other industry leaders.
"I am excited about the partnership between Corindus and CRT," said Ron Waksman, MD, CRT 2016 Course Chairman. "I know first-hand about the benefits of the CorPath System, and count myself among the pioneers who brought this technology to MedStar Washington Hospital Center. It is important that physicians understand their need for protection in the cath lab, and that the CorPath System can be a solution to risks they face on a daily basis."

For the first time, the CRT conference features a special transradial intervention master’s course. Radial access is widely considered the standard of care outside the U.S. and, while data has shown that it improves clinical outcomes by reducing PCI-related complications for the patient, it is also known to increase radiation exposure to the operator.

"Radiation exposure protection provided by the CorPath System becomes increasingly important as more physicians adopt radial access as a standard practice," said David Handler, President and CEO, Corindus. "We are excited to participate in the radial master’s course and look forward to highlighting CorPath robotic-assisted PCI at CRT, a conference that brings the latest clinical research and technological advancements to the interventional community."

More HCB News